| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |